Abstract
Despite the increasing life expectancy, an individual’s later years tends to be accompanied by a decrease in the quality of life. Though biological changes that occur through the natural process of aging cannot be controlled, the risk factors associated with lifestyle can. Thus, the main goal of this systematic review was to evaluate how nutrition can modulate aging. For this purpose, thirty-six studies were selected on (i) the efficiency of nutrition’s effect on aging, (ii) the evaluation of biomarkers that promote healthy aging, and (iii) how to increase longevity through nutrition, and their quality was assessed. The results showed that choosing low carbohydrate diets or diets rich in vegetables, fruits, nuts, cereals, fish, and unsaturated fats, containing antioxidants, potassium, and omega-3 decreased cardiovascular diseases and obesity risk, protected the brain from aging, reduced the risk of telomere shortening, and promoted an overall healthier life. With this study, the conclusion is that since the biological processes of aging cannot be controlled, changing one’s nutritional patterns is crucial to prevent the emergence and development of diseases, boost longevity, and, mostly, to enhance one’s quality of life and promote healthy aging.
1. Introduction
Aging is the gradual process of natural changes that occur throughout the human lifespan. This process begins in early adulthood; throughout the years, many mental and bodily functions begin to slowly decline, resulting in health issues, such as increased morbidity and decreased fertility [1,2,3]. Over the years, life expectancy has risen, with approximately 8% of the world population being over 65 years old, and in approximately 30 years, this number is expected to double [4]. However, this does not necessarily mean that people experience better health in their later years when compared with other generations [5,6].
In fact, despite the life expectancy increase, aging is a mechanism that has multifaceted features that are linked: molecular, cellular, physiological, and functional levels that ultimately lead to chronic diseases [7]. At the molecular level, aging is represented by genomic instability, telomere attrition (as they tend to shorten), epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, stem cell exhaustion, and altered intercellular communication, which are believed to be decisive to determine one’s lifespan [8]. These risk factors might impact the cellular level by deregulating signaling; thus, causing cellular senescence and mitochondrial dysfunction [9]. Consequently, the physiological and functional levels weaken, triggering the development of chronic inflammation, alterations in energy metabolism, such as variations in insulin sensitivity, undermining neuronal [10], and sensory functions, mainly visual, auditory, and touching (or movement) [11,12]. On a physical level, hair normally turns white, thinner, and takes longer to grow, and the skin becomes less elastic and more wrinkled, as a result of less efficient vitamin D synthesis [13]. Moreover, there are some factors that are usually associated with specific disorders that might appear: hyperglycemia, hypercholesterolemia, and hypertension [14]. Altogether, these effects give rise to numerous age-associated disorders that result from these alterations, such as sarcopenia, represented by the decline in skeletal muscle mass, and, therefore, weakening physical functioning, which is derived from chronic inflammation, hormonal changes, cell dysfunction, an unhealthy diet, lack of physical activity [15], neurodegenerative diseases, heart diseases, diabetes, and cancer [16,17].
Despite the biological changes associated with aging, there are risk factors, such as lifestyle and dietary patterns [18,19], which, if altered, can promote healthy aging, and are characterized by the development and maintenance of the functional abilities that enable one’s wellbeing [20]. Healthy lifestyles promote the maintenance of cognitive abilities and boost the immune system [18,19,21,22]. Studies show that adoption of a Mediterranean diet, characterized by a decreased consumption of saturated animal fat and red meat and a higher intake of fruits and vegetables, along with maintaining a healthy weight and reducing salt intake [23,24,25,26], and lifestyle changes, such as engaging in physical and social activities and reducing smoking and alcohol consumption, can significantly modulate the inflammatory state of the body. Consequently, general health improves throughout the diverse stages of life [23,27,28]. It is also believed that these key factors may be viewed from a life-course perspective since a change of these routines can shape the rate at which human cells or organs enter in senescence, delay the onset of chronic diseases, and promote mobility, mental function, and wellbeing [23,29]. However, the main “gaps” remain as to what types of diets or what food components could actually improve healthy aging, and what biomarkers are modulated by the diet and associated with chronic diseases, in order for them to be considered more when evaluating or preventing the incidence of these diseases.
To address these gaps, the main goal of this systematic review was to perceive the quantity and quality of different diets or aspects in nutrition, how they could modulate biomarkers and prevent aging-related diseases, in order to enlighten new intervention strategies. Biomarkers that are linked to aging-associated metabolism, inflammation processes, cognitive decline, and telomere attrition were scrutinized in order to understand how these mechanisms could actually influence healthy aging. Moreover, it could provide information to future health professionals.
2. Materials and Methods
2.1. Protocol and Registration
This systematic review followed the PRISMA statement guidelines, and it was recorded in the international database of prospectively registered systematic reviews (PROSPERO)—registration number CRD42021244473 [30].
2.2. Search Strategy and Inclusion Criteria
For this systematic review, searches were conducted in PubMed scientific databases on 28 February 2021.
The search was conducted by two independent researchers, and it was primarily designed to spot relevant studies on the efficacy of nutrition’s effect on aging, on the evaluation of molecules that promote healthy aging, and on how to increase longevity through nutrition. The following keywords and their equivalents were used in PubMed:
“(diet* OR nutri*) AND (age OR ageing OR aging OR old OR older OR elder*) AND (marker OR biomarker)”
The selection criteria applied in this review were the following: (1) language: documents had to be published in English; (2) published studies from 1 January 2010 to 28 February 2021; (3) participants/population: adults/humans; (4) types of studies to include: randomized and non-randomized trials (including clusters—randomized and clusters—non-randomized), and observational studies (including case control, cross sectional, cohort, before and after, and interrupted time series). Study protocols, reviews, systematic reviews, and meta-analysis were excluded. The included studies assessed the importance of a healthy diet in order to ensure healthy aging through the study of the molecules involved. All studies that mentioned this impact were considered.
All titles retrieved from database were reviewed independently; the inclusion and exclusion criteria were applied by two independent researchers (A.M. and C.L.) and validated by a third researcher (M.E.) in cases where there was no consensus.
2.3. Quality Assessment of the Included Studies
The quality assessment of the included studies involves using five criteria [31]: (1) study group allocation: random: 2; quasi-random: 1; selected controls: 0; (2) allocation unit: cluster (for example, practice): 2; physicians/physiotherapists/researchers: 1; patients: 0; (3) baseline differences: presence of baseline differences with statistical adjustments: 2; baseline differences with no statistical adjustments: 1; absence baseline differences: 0; (4) objectivity of the result: blinded assessment: 2; no blinding but defined assessment criteria: 1; no blinding and poorly defined: 0; (5) completeness of follow-up: ≥90%: 2; 80–90%: 1; <80% or not described: 0.
All studies were scored from 0 to 10, based on the sum of the scores for each parameter and it was evaluated by two independent researchers (A. M. and C. L.). Higher scores indicate higher quality research.
2.4. Data Extraction and Analysis
The articles that met the inclusion criteria were summarized in a table for: author and publication year; study design, country, setting, study population, sample size, participants’ characteristics, and the main results and involved biomarkers. Two independent researchers (A.M. and C.L.) extracted data and compared their findings. In cases of disagreement, a third reviewer (M.E.) served as a referee to help reach an agreement.
3. Results
3.1. Study Selection
The search strategy involved retrieving 9709 citations from PubMed–MEDLINE database, the eligible articles were carefully chosen based on the title and abstract. In the first version of this systematic review, five studies were selected. Despite these studies not appearing in the chosen string of keywords, they were present in the bibliography of the studies identified from the database. Those studies were first selected on the title, resulting in 1264 studies, and after selection based on the abstract, 163 studies were analyzed. These 163 studies were evaluated based on their full-texts, in which 31 were deemed suitable for inclusion in the current review [32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67] (Figure 1).
Figure 1.
Application of search strategies to retrieve the total number of studies for analysis.
3.2. Quality Assessment
The quality of all of the included studies was assessed [31]. The median score for all of the studies was 6/10. Seven studies received a score of 4 or less out of 10 [38,48,52,55,58,64,66]. Fifty-eight percent of the studies had a total score of 5–7 out of 10 [32,33,35,36,39,40,41,42,44,46,47,49,51,53,54,56,57,61,62,63,65]. Eight studies received a score of 8 or higher out of 10 [34,37,43,45,50,59,60,67]. The results are presented in Supplementary Material (Table S1).
3.3. Study Characteristics
Table 1 summarizes the study characteristics of the included papers. This table presents information from the included articles on the study design, country, setting, study population, sample size, participants’ characteristics (age, gender, body mass index (BMI), and if they had any disease), and data collection procedures.
Table 1.
Synthesis of the studies’ characteristics.
3.3.1. Study Design
A total of 12 of the 36 included studies were randomized controlled trials [33,34,37,41,43,50,56,57,59,60,61,67], 8 were cross-sectional studies [36,39,40,44,45,49,51,58], 6 were prospective cohort studies [32,47,55,63,64,65], 4 were cohort studies [46,52,62,66], 2 were crossover studies [38,53], 2 were randomized non-controlled trials [35,42], and 2 were prospective non-randomized: pre/post studies [48,54].
3.3.2. Location
Most studies (55.6%) were conducted in Europe [32,34,37,38,40,41,42,43,44,46,47,49,50,54,56,58,59,61,62,63]. Nine studies (25%) took place in North America [35,36,39,52,53,55,57,64,66], six were undertaken in Asia [33,45,48,51,60,65], and one study was carried out in Australia [67].
3.3.3. Setting
The majority of studies (61.1%) were conducted in academic medical centers [32,36,37,39,40,44,46,47,48,49,51,52,53,54,55,57,59,60,62,63,66,67]. Fourteen of the thirty-six interventions (38.9%) occurred in the context of hospital care [33,34,35,38,41,42,43,45,50,56,58,61,64,65], with nine of them in university hospitals [35,38,41,42,56,58,61,64,65].
3.3.4. Sample Size and Study Population
Twelve of the thirty-six (33.3%) included studies presented a sample size under 100 participants [33,35,38,41,42,48,52,53,56,60,61,67], thirteen studies (36.1%) had a sample size between 100 and 1000 participants [32,34,37,43,45,50,51,54,55,57,59,62,65], nine (25%) between 1000 and 10,000 [36,39,44,46,47,49,58,64,66], and two had more than 10,000 participants [40,63].
Twenty two of the thirty-six included studies examined the results based on the adult population [32,33,35,36,37,40,46,47,48,49,52,53,54,55,57,58,59,60,63,64,66,67] and fourteen only recruited older adults [34,38,39,41,42,43,44,45,50,51,56,61,62,65].
All of the studies were based on age and gender (both genders, only men or only women) to select the participants. Six of the thirty-six studies (19.4%) included participants with type-1 diabetes (T1D), type-2 diabetes (T2D), mild cognitive impairment (MCI), and cardiovascular disease (CVD), or who were at risk of suffering from these diseases [34,35,37,43,50,53,55], and half of the studies had specific BMI [35,36,37,41,42,44,48,52,54,55,56,57,59,60,61,62,65,67] as inclusion criteria.
3.3.5. Influence of Different Types of Diet on Biomarkers
All of the studies aimed to evaluate the nutritional state, as described in our main goal. Besides the nutritional state, eight of the studies also considered telomere length [32,36,37,39,58,62,64,66] and five of the studies evaluated nutritional state effects in cognitive decline [33,50,52,53,65]. The main molecular outcomes and the tested biomarkers are described in Table 2.
Table 2.
Summary of the included studies’ results of outcomes related to molecular output and related biomarkers.
The ketogenic diet (KD) reduced CVD risk by improving CVD biomarkers (Figure 2) in T2D patients and decreasing inflammation [55]. It also prevented brain aging (Figure 3) by avoiding the destabilization of brain network and network switching [52]. Network stability is represented by the ability of the brain to maintain functional communication between its regions, and when this process is affected, network switching occurs from the largescale reorganization of the network modules. Moreover, the Mediterranean diet (MedDiet) regulated the relationship between genetic risk factors and cognition [50], protecting participants with specific variants of the CR1 gene (without A minor allele of the rs3818361), the CLU gene (with T minor allele of the rs11136000), the PICALM gene (with T minor allele of the rs3851179), and both non-ApoE4 and ApoE4 carriers. Variations in this diet, such as the modified Mediterranean–ketogenic diet (MMKD), prevented cognitive decline (Figure 3) in adults with Alzheimer’s disease (AD) risk, by increasing amyloid-beta 42 (Aβ42) and decreasing tau expression [53].
Figure 2.
Influence of diets in cardiovascular diseases hallmarks and inflammation.
Figure 3.
Influence of different diets in brain aging (up) and in aging-related disease/hallmarks (down).
The modified Alternative Healthy Eating Index (mAHEI) was used to assess diet quality in an older Chinese population, considering consumption of fruits, vegetables, soy protein, fish/meat/eggs, whole grain, fried foods, and alcohol [65]. In this study, a high diet quality combined with a varied vegetable intake was linked to a lower risk of cognitive decline (Figure 3). Daily intake of green tea catechins demonstrated beneficial effects on working memory in adults, by decreasing the commission errors in the continuous performance test (CPT), and the time response in the 4-part CPT (FPCPT) [33].
The MedDiet demonstrated beneficial effects in several key points. The role of the dietary inflammatory index (DII) used this diet in telomere shortening (Figure 3) [37]. An anti-inflammatory diet, rich in antioxidants, could reduce the rate of telomere shortening, by improving telomerase activity [62] in individuals at high risk of CVD [37,39,62,66]. In addition, diets rich in fibers, vegetables, and fruits, and poor in meat, dairy products, and PUFAs, as well as waist circumference (WC) reduction, are beneficial in improving leukocyte telomere length (Figure 3) [39,58,64]. In contrast, consumption of ultra-processed foods (UPFs) and processed meat was negatively associated with MedDiet adherence, and it was positively related with a higher risk of having shorter telomeres (Figure 3) [32,36,63]. UPF was also linked to an increased risk of CVD, ischemic heart disease (IHD)/cerebrovascular disease, and all-cause mortality (Figure 3) [63].
Cardiovascular risk factors (Figure 2) were also attenuated in the presence of a dietary approach to stop hypertension (DASH) pattern, decreasing the levels of fibrinogen, insulin, and diastolic blood pressure (DBP) [45]. In contrast to a Western diet-like high-fat (WDHF) and a Western diet-like high-carbohydrate (WDHC), MedDiet meals promote positive effects on glycemic insulinemic, and lipemic responses (Figure 2), due to lower levels of glucose, insulin, triglycerides, and non-esterified fatty acids (NEFAs) [56]. The ketogenic–Mediterranean diet, supplemented with phytoextracts (KEMEPHY), also led to reductions in weight, BMI, WC, % fat mass, total cholesterol, LDL-C, triglycerides, and blood glucose, and increases in HDL-C [54].
A healthy Nordic diet reduced non-high-density lipoprotein cholesterol (non-HDL-C), low-density lipoprotein cholesterol (LDL-C)/HDL-C ratio, apolipoprotein B (ApoB)/apolipoprotein A1 (ApoA1) ratio, and interleukin-1 receptor antagonist (IL-1 Ra), improving lipid profile (Figure 2), and having a beneficial effect on low-grade inflammation [59]. The Southern European Atlantic diet (SEAD), a common diet in the Iberian Peninsula, enabled reduced concentrations of C-reactive protein (CRP), triglycerides, and insulin, which could help prevent myocardial infarction [40]. Diets rich in potassium intake attenuated CVD risk (Figure 2) since they prevented cardiomyocyte injury, through high-sensitivity cardiac troponin T (hs-cTnT) and cardiac dysfunction, through N-terminal pro-B-type natriuretic peptide (NT-proBNP) [49]. A restricted-calorie diet (RCD), allied to daily consumption of grape seed extraction (GSE), improved blood lipid profile and helped ameliorate some CVD risk factors (Figure 2), by reducing LDL-C, total cholesterol, the triglycerides visceral adiposity index, and the plasma atherogenic index. Moreover, it promoted higher levels of HDL-C and HDL-C/LDL-C ratio in obese or overweight adults [60]. A low-fat high-carbohydrate (LFHC) diet reduced weight, fat mass, fasting leptin, and adiponectin levels, when compared to a moderate-fat diet (18% protein, 36% fat, 46% carbohydrate) [57].
In older adults, a low-fat diet rich in fibers, improved periodontal disease markers, such as clinical attachment loss (CAL), bleeding on probe (BOP), probing depth (PD), and gingival crevicular fluid (GSF), as well as on the metabolic profile (body weight, hs-CRP and glycated hemoglobin) [48].
A modified version of MedDiet score, Elderly Dietary Index (EDI), which evaluates elderly adherence to dietary recommendations, was associated with reduced weight, BMI, WC, insulin, fibrinogen, diastolic blood pressure, homeostasis model assessment-insulin resistance (HOMA-IR), alanine aminotransferase (ALT), aspartate aminotransferase, and higher HDL-C concentrations, fasting blood sugar, total cholesterol, and quantitative insulin sensitivity check index (QUICKI) [51].
Fruit consumption, both in fruit or in juice, reduced several cardiometabolic risk factors (Figure 2), such as BMI, WC, glucose levels, and LDL-C in elders with metabolic syndrome [44]. Fruit-based anthocyanins also mitigated the negative effects of a high fat high energy (HFHE) diet, by decreasing inflammatory biomarkers, such as CRP and interleukin-6 (IL-6) [67].
MedDiet also decreased hepatic steatosis risk, based on the fatty liver index [47]. A low-fat diet and MedDiet decreased weight, BMI, WC, and triglyceride levels, in adults with T1D and metabolic syndrome (MetS) [35]. MedDiet also decreased atherothrombosis biomarkers (Figure 3), such as platelet activating factor acetylhydrolase (PAF-AH), HDL-bound α1-antitrypsin, fibrinogen and NEFAs in older adults with high cardiovascular risk [43]. In older adults, MedDiet supplemented with coenzyme Q10 (MedDiet + CoQ) promoted higher excretion of urinary metabolites, such as hippurate (Figure 3) related to oxidative stress, in comparison with a saturated fat (SFA) diet [38]. The MedDiet + CoQ also positively modulated the inflammatory response and ER stress [61], by decreasing p65 (protein involved in NF-κB heterodimer formation, nuclear translocation and activation), inhibitor of nuclear factor kappa-B kinase (IKK-b) and interleukin-1b (IL-1b) mRNA levels. Moreover, it protected DNA from oxidative damage, by reducing the activation of p53, and, consequently, downregulated the expression of genes Gadd45a, Gadd45b, OGG1, APE1/Ref-1, DNA polβ, and XPC, all linked to p53-dependent DNA repair [41,42].
A Nordic alternative to the MedDiet, the Baltic Sea Diet, was evaluated regarding inflammation markers (Figure 3), and a reduction of high-sensitivity C-reactive protein (hs-CRP) was noted [46]. Consumption of a MedDiet supplemented with virgin olive oil (MedDiet + VOO) demonstrated protective effects on the bones (Figure 3), by increasing serum osteocalcin [34].
4. Discussion
This systematic review was accomplished to, first, demonstrate how different diets or different aspects in nutrition impact aging-related diseases, and second, to pinpoint putative molecular markers that change with diet and nutrition along aging. The results of the studies analyzed in this systematic review show that avoiding unhealthy habits, mainly concerning diets, may improve life quality and promote healthy aging (Figure 2 and Figure 3).
The diets studied in this systematic review presented diverse similarities. KD is a low-carbohydrate diet, whereas MedDiet is based on low consumption of saturated animal fat and red meat, and a high intake of fruits, vegetables, fish, olive oil, nuts, and vitamins [68]. The DASH diet pattern is very similar to MedDiet, since it is rich in the same products and poor in SFAs, added sugars, sodium, and refined carbohydrates [69]. The KEMEPHY diet maintains the use of vegetables and olive oil just like the MedDiet [70], but presents elevated ketone bodies in the blood or urine [71]. The SEAD is represented by high intakes of fresh fish, red meat, and pork products, legumes and vegetables, vegetable soup, potatoes, dairy products, whole-grain bread, and wine [40]. The Baltic Sea diet is described as a variant of the MedDiet with healthy Nordic foods [72]. The healthy Nordic diet is based on the consumption of whole-grain products, abundant intake of berries, fruits, and vegetables, rapeseed oil, three fish meals per week, low-fat dairy products, and a reduction of sugar-sweetened products [59]. The MMKD is a very low-carbohydrate diet that is modeled on a MedDiet, emphasizing protein sources low in saturated fat (fish, lean meats), healthy fats, fruit and vegetable consumption, whole grains, and a glass of wine per day [53].
The adoption of a KD reduced CVD risk, by improving CVD biomarkers (Figure 3) in T2D patients, and decreased inflammation [55,73,74,75]. Since inflammation has a role in every facet of CVD pathogenesis [76] and hs-CRP and WBC count are well-established markers of inflammation and risk factors for CVD [77,78], the decrease of these markers in the CCI indicated that inflammation was diminished after 1 year of intervention. KD also protected brain aging (Figure 2) by avoiding the destabilization of the brain network, which is what happens when glucose is used as fuel [52]. These stabilizing effects of nutritional ketosis were replicated when exogenous ketones were administrated, suggesting that they were specifically due to glucose metabolism rather than ketone body metabolism [52]. Furthermore, it supports the hypothesis that there are some beneficial neural effects associated with the hypocaloric state; intermittent fasting and severe caloric restriction may result from the use of ketone bodies by the brain [79].
The MedDiet modulated the impact of genetic risk factors on cognition (Figure 3) [50]. The variants studied have been associated as risk factors for AD [80,81,82] and cognitive decline, mainly with poor memory performance in population-based studies [83,84]. The MedDiet has already been revealed as protective in cognitive functioning [85], cognitive decline [86], and the development of mild cognitive impairment and dementia [87,88]. Daily intake of green tea catechins also demonstrated beneficial effects on the working memories in adults [33,89,90]. The MMKD prevented cognitive decline (Figure 3) in adults with Alzheimer’s disease (AD) risk, by increasing Aβ42 and decreasing tau expression [53]. Moreover, a high diet quality that prioritizes foods that are the base of the KD and MedDiet, allied to a diverse vegetable intake, was linked to a decrease of cognitive decline risk [65]. This was supported by previous studies that demonstrated that dietary interventions had a huge impact on cognitive deterioration [91]. Additionally, this protective effect may be due to individual characteristics of foods. Antioxidants and phenolic compounds can minimize oxidative damage and inflammation, and boost neuronal antioxidant defenses [92,93].
The MedDiet was used to assess the role of DII in telomere shortening, proving that an anti-inflammatory diet or one rich in antioxidants could reduce the rate of telomere shortening in individuals at a high risk of CVD [37]. Studies that evaluated adherence to the MedDiet achieved the same conclusions [39,62,66,94,95,96,97].
Higher consumptions of vegetables [58] and diets rich in fibers [39,64] were also positively associated with leukocyte telomere length, as well as lower WC, whereas SFAs were negatively linked [58]. Thus, an anti-inflammatory diet can avoid telomere shortening and, consequently, reduce the impact of aging and cancer development [98]. In contrast, consumption of UPF and processed meat was linked to an increased risk of having shorter telomeres [32,36]. UPFs are industrial formulations of food-derived substances (oils, fats, sugars, starch, protein isolates) that include flavorings, colorings, emulsifiers, and other cosmetic additives [32]. UPFs have been linked with several diseases, such as hypertension [99], obesity [100], MetS [100], T2D [101], and cancer [101]. Higher total intakes of salt, saturated fat, and sugar, as well as inadequate intakes of fiber and minerals, could explain the association between UPF consumption and the risk of developing short telomeres. [102].
The MedDiet [35,47,56], or its components [44,67], RCD, allied to daily consumption of GSE [60], DASH patterns [45], LFHC diet [57], the Baltic Sea diet [46], the Nordic diet [59], SEAD [40], the KEMEPHY diet [54], or the use of EDI scores to assess MedDiet adherence [51], promoted decreased inflammatory markers and improved cardiometabolic risk factors (Figure 2), including components that belong to MetS. MetS is one of the most significant risk factors associated with CVD [103,104] and it is defined as having at least three of the following characteristics: (i) central obesity, (ii) increased serum triglyceride levels, (iii) low HDL levels in the blood, (iv) cholesterol levels, (v) hypertension, and (vi) higher fasting blood glucose levels [104]. Since these diets are very similar, this might explain the similar results. In several studies, researchers note that the MedDiet is able to prevent CVD [24,26,68,105]; this effect is due to the combination of different foods that have anti-inflammatory properties. The DASH diet pattern was already established as a potential treatment for hypertension [106], to reduce both fasting and postprandial insulin concentrations [107], and CRP levels [108,109]. The KEMEPHY diet, by inducing a physiological ketosis through elevated ketone bodies present in blood or urine [71], stimulates positive changes in cardiovascular risk factors and body composition [110].
SEAD, just like the MedDiet, is rich in folate and vitamin C from vegetables, as well as omega-3 fatty acids from fish; these compounds have already been connected with reduced insulin [111,112] and low hs-CRP [113]. This inflammatory marker was also reduced in this diet, suggesting that it may reduce CVD risk (Figure 2). The Baltic Sea diet also promotes the reduction of CRP concentrations (Figure 2), due to the presence of Nordic fruits and berries and cereals [46]. They contain antioxidant components, such as polyphenols, minerals, vitamins, and dietary fibers, which diminish these levels and the release of E-selectin [114,115]. This molecule is produced and released into circulation during endothelial injury, and its reduction improves endothelial function [115]. The healthy Nordic diet decreases IL-1 Ra [59], which is one of the most sensitive inflammatory markers, in obesity and MetS. It has been associated with high intakes of SFAs and lower consumption of berries, fruits, and whole-grain products [116,117,118]. Moreover, higher levels of IL-1 Ra have been revealed to predict T2D and the progression of MetS to T2D [116]. In addition, this healthy Nordic diet promotes the reduction of non-HDL-C and LDL-C, which are designated to have an important impact on CVD morbidity and mortality [119,120]. CVD risk is also attenuated by high intakes of potassium (Figure 2) due to its nonlinear association with CVD biomarkers (Figure 2) [49,121,122], which is supported by previous studies [123,124,125], thus endorsing the World Health Organization (WHO) recommendation that adults increase their potassium intake [126]. In contrast, CVD, IHD/cerebrovascular disease, and all-cause mortality was linked to UPF consumption [63,127,128,129].
The MedDiet also decreases risk factors associated with other comorbidities (Figure 3), such as hepatic steatosis [47], atherothrombosis [43], oxidative stress, by promoting the excretion of urinary metabolites [38], and, allied to virgin olive oil, demonstrates protective effects on bone tissue, by increasing serum osteocalcin [34].
The MedDiet, allied to a supplementation of CoQ, was shown to protect DNA from oxidative damage (Figure 3) by reducing the activation of p53 [41] and, consequently, the expression of genes involved in p53-dependent DNA repair were downregulated [42]. Previous studies demonstrated that DNA damage plays an important role in the pathogenesis of atherosclerosis (buildup of fats, cholesterol, and other substances in and on the artery walls), as well as other aging-related diseases [130]. As for diets rich in PUFAs—CoQ supplements have been shown to mitigate oxidative and lipid peroxidation chain reaction damage [131,132], regenerate other antioxidants, such as α-tocopherol and ascorbate [133,134,135], and reduce CVD risk and inflammation [131]. The fatty acid content of cellular membranes and fluids is linked to oxidative stress, so it was expected that MedDiet + CoQ helped prevent this event [136,137,138]. Furthermore, recent research has shown that changes in the expression of p53 and the p53-regulated DNA damage response genes, such as gadd45a and mdm2, can be used as genotoxic and carcinogenic stress markers [139,140]. This diet also has an additional influence on the inflammatory response and ER stress [61], since it reduces the p65, IKK-b, and IL-1b gene expression.
A low-fat diet rich in fibers has demonstrated protective effects on periodontal disease (Figure 3), by reducing its biomarkers in older adults [48]. This disease has already been associated with obesity [109,141]. Other studies reported on how weight reduction promotes a decrease in system inflammation, as well as a loss of adipose tissue [142], and since hs-CRP was decreased in this study, obesity and periodontal disease may be connected by inflammation [142].
In contrast, previous studies [143,144,145,146,147,148,149] have demonstrated that unhealthy habits, such as westernized diets (high intakes of red meat, processed foods, ‘‘fast-foods’’, high-fat dairy products, snacks, and sugary soft drinks, and low intakes of fruits, vegetables, vitamins, and minerals), lack of physical activity, alcohol consumption, or smoking can potentiate the risk of development of diabetes, obesity, cardiovascular diseases, and cancer. Thus, even in the absence of traditional CVD risk factors (smoking, T2D, high BP, and elevated levels of cholesterol), weight-loss strategies should always be recommended in order to keep a healthy body weight to decrease CVD and other comorbidities risk.
Despite the insights provided in this systematic review, there is still much information that needs further research. Designing proper diets and addressing new strategies to combine them with different types of physical activity should be further explored. Moreover, extending this type of research to the cancer field may help in the discovery of new biomarkers that can promote an early diagnosis and treatment or novel approaches to prevention
This systematic review has several strengths, specifically, the extensive and systematic research of articles on the stated theme and information concerning the different effects of multiple diets. This study sought to compact different diets and food components that help decrease the prevalence and severity of several diseases, such as cardiovascular diseases, obesity risk, brain diseases, and even, delay the progression of cancer, through the reduction of telomere shortening. These results are of major importance to the development of new interventions in nutrition targeting aging-related biomarkers. However, this systematic review also presents some limitations. One of the limitations is the use of only one database (PubMed), which may have resulted in a failure to consider other potentially relevant articles on other databases. Another limitation was the difficulty to organize and structure the types of diets and biomarkers, since they present different effects. Finally, some of the biomarkers analyzed in this systematic review are not always valid for certain health outcomes, since they can be considered subrogated variables.
5. Conclusions
In conclusion, this systematic review demonstrated the necessity for individuals to improve their diets, to reduce the emergence and development of several comorbidities and promote healthy aging. Diets rich in vegetables, fruits, nuts, cereals, fibers, fish, unsaturated fats, containing antioxidants, vitamins, potassium, omega-3—and reducing red meat and UPF intake—could prevent obesity, CVD, and inflammation, and promote favorable glycemic, insulinemic, and lipidemic responses. Moreover, the MedDiet and KD, or a combination of these diets (MMKD), and increasing consumption of vegetables and green tea catechins, could improve one‘s working memory and decrease destabilization of the brain network and the attention domain, preventing cognitive decline. Finally, the MedDiet, supplemented with CoQ or VOO, or a low-fat diet, also rich in antioxidants, could help to decrease the prevalence of atherothrombosis, hepatic steatosis, diabetes, and telomere attrition, as well as prevent oxidative and DNA damage. These diets can enhance one‘s quality of life and increase life expectancy. Moreover, a putative panel of molecular markers (see Figure 2 and Figure 3) would follow the impact of diet/nutrition alterations during aging.
Supplementary Materials
The following are available online at https://www.mdpi.com/article/10.3390/nu14030554/s1, Table S1: Quality assessment of the selected articles.
Author Contributions
Conceptualization, M.T.H., F.R., M.F.; methodology, M.E., M.T.H., F.R., M.F., A.F.; validation, M.E., M.T.H.., F.R., M.F.; formal analysis, C.L., A.M., M.E., M.T.H., F.R., M.F., A.F.; writing—original draft preparation, C.L., A.M.; writing—review and editing, C.L., A.M., M.E., M.T.H., F.R., M.F., A.F.; visualization, C.L., A.M., M.E., M.T.H., F.R., M.F., A.F.; supervision, M.T.H., F.R., M.F.; project administration, M.T.H., F.R., M.F. All authors have read and agreed to the published version of the manuscript.
Funding
This study was funded by the Institute for Biomedicine—iBiMED (UIDB/04501/2020) and by Fundação para Ciência e Tecnologia—FCT (UI/DB/151352/2021).
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
Not applicable.
Acknowledgments
This study was supported by the Institute for Biomedicine—iBiMED (UIDB/04501/2020).
Conflicts of Interest
The authors declare no conflict of interest.
References
- Partridge, L.; Gems, D. Mechanisms of aging: Public or private? Nat. Rev. Genet. 2002, 3, 165–175. [Google Scholar] [CrossRef] [PubMed]
- Kirkwood, T.B.L.; Austad, S.N. Why do we age? Nature 2000, 408, 233–238. [Google Scholar] [CrossRef] [PubMed]
- Partridge, L.; Gems, D.; Charlesworth, B. The evolution of longevity primarily by the work of Bill. Curr. Biol. 2002, 12, 544–546. [Google Scholar] [CrossRef]
- United Nations, Department of Economic and Social Affairs PD. World Population Ageing 2019; United Nations, Department of Economic and Social Affairs PD: New York, NY, USA, 2019. [Google Scholar]
- Robine, J.; Saito, Y.; Jagger, C. The relationship between longevity and healthy life expectancy. Qual Ageing 2009, 10, 4–15. [Google Scholar] [CrossRef]
- Calder, P.C.; Carding, S.R.; Christopher, G.; Kuh, D.; Langley-Evans, S.C.; McNulty, H. A holistic approach to healthy ageing: How can people live longer, healthier lives? J. Hum. Nutr. Diet. 2018, 31, 439–450. [Google Scholar] [CrossRef]
- Marsman, D.; Belsky, D.W.; Gregori, D.; Johnson, M.A.; Dog, T.L.; Meydani, S.; Pigat, S.; Sadana, R.; Shao, A.; Griffiths, J.C. Healthy ageing: The natural consequences of good nutrition—A conference report. Eur. J. Nutr. 2018, 57, S15–S34. [Google Scholar] [CrossRef]
- Aunan, J.R.; Watson, M.M.; Hagland, H.R.; Søreide, K. Molecular and biological hallmarks of ageing. Br. J. Surg. 2016, 103, e29–e46. [Google Scholar] [CrossRef]
- López-Otín, C.; Blasco, M.A.; Partridge, L.; Serrano, M.; Kroemer, G. The Hallmarks of Aging Europe PMC Funders Group. Cell 2013, 153, 1194–1217. [Google Scholar] [CrossRef]
- Zinger, A.; Cho, W.C.; Ben-yehuda, A. Cancer and Aging—The Inflammatory Connection. Aging Dis. 2017, 8, 611–627. [Google Scholar] [CrossRef]
- Wysokiński, A.; Sobów, T.; Kłoszewska, I.; Kostka, T. Mechanisms of the anorexia of aging—A review. Age 2015, 37, 81. [Google Scholar] [CrossRef]
- Kauppinen, A.; Paterno, J.J.; Blasiak, J.; Salminen, A.; Kaarniranta, K. Inflammation and its role in age -related macular degeneration. Cell. Mol. Life Sci. 2016, 73, 1765–1786. [Google Scholar] [CrossRef]
- Bonté, F.; Girard, D.; Archambault, J.; Desmoulière, A. Skin Changes During Ageing. In Biochemistry and Cell Biology of Ageing: Part II Clinical Science; Springer: Singapore, 2019. [Google Scholar] [CrossRef]
- Singh, G.M.; Danaei, G.; Pelizzari, P.; Lin, J.K.; Cowan, M.J.; Stevens, G.A.; Farzadfar, F.; Khang, Y.-H.; Lu, Y.; Riley, L.M.; et al. The Age Associations of Blood Pressure, Cholesterol, and Glucose Analysis of Health Examination Surveys from International Populations. Circulation 2012, 125, 2204–2211. [Google Scholar] [CrossRef]
- Ziaaldini, M.M.; Marzetti, E.; Picca, A.; Murlasits, Z. Biochemical Pathways of Sarcopenia and Their Modulation by Physical exercise: A Narrative Review. Front. Med. 2017, 4, 167. [Google Scholar] [CrossRef]
- Hung, C.; Chen, Y.; Hsieh, W.; Chiou, S.; Kao, C. Ageing and neurodegenerative diseases. Ageing Res. Rev. 2010, 9, S36–S46. [Google Scholar] [CrossRef]
- Freid, V.M.; Bernstein, A.B.; Bush, M.A. Multiple Chronic Conditions Among Adults Aged 45 and Over: Trends Over the Past 10 Years. NCHS Data Briefs 2012, 1–8. [Google Scholar]
- Chiuve, S.E.; Mccullough, M.L.; Sacks, F.M.; Rimm, E.B. Healthy Lifestyle Factors in the Primary Prevention of Coronary Heart Disease Among Men. Circulation 2006, 114, 160–167. [Google Scholar] [CrossRef]
- King, D.E.; Mainous, A.G., III; Matheson, E.M.; Everett, C.J. Impact of healthy lifestyle on mortality in people with normal blood pressure, LDL cholesterol, and C-reactive protein. Eur. J. Precentive Cardiol. 2011, 20, 73–79. [Google Scholar] [CrossRef]
- World Health Organization. Ageing: Healthy Ageing and Functional Ability 2020. Available online: https://www.who.int/%0Aageing/healthy-ageing/en/ (accessed on 10 May 2021).
- Mathers, J.C. Nutrition and ageing: Knowledge, gaps and research priorities. Proc. Nutr. Soc. 2013, 72, 246–250. [Google Scholar] [CrossRef]
- Jong, J.C.K.; Mathers, J.C.; Franco, O.H. Nutrition and healthy ageing: The key ingredients. Proc. Nutr. Soc. 2014, 73, 249–259. [Google Scholar] [CrossRef]
- Stanner, S. Healthy ageing: The role of nutrition and lifestyle. Nurs. Resid. Care 2009, 11, 243–245. [Google Scholar] [CrossRef]
- Martini, D. Health Benefits of Mediterranean Diet. Nutrients 2019, 11, 1802. [Google Scholar] [CrossRef]
- Tyrovolas, S.; Haro, J.M.; Mariolis, A.; Piscopo, S.; Valacchi, G.; Tsakountakis, N.; Zeimbekis, A.; Tyrovola, D.; Bountziouka, V.; Gotsis, E.; et al. Successful aging, dietary habits and health status of elderly individuals: A k -dimensional approach within the multi-national MEDIS study. Exp. Gerontol. 2014, 60, 57–63. [Google Scholar] [CrossRef]
- Galbete, C.; Schwingshackl, L.; Schulze, M.B. Evaluating Mediterranean diet and risk of chronic disease in cohort studies: An umbrella review of meta-analyses. Eur. J. Epidemiol. 2018, 33, 909–931. [Google Scholar] [CrossRef]
- Daskalopoulou, C.; Stubbs, B.; Kralj, C.; Koukounari, A.; Prince, M.; Prina, A.M. Physical activity and healthy ageing: A systematic review and meta-analysis of longitudinal cohort studies. Ageing Res. Rev. 2017, 38, 6–17. [Google Scholar] [CrossRef]
- Daskalopoulou, C.; Stubbs, B.; Kralj, C.; Koukounari, A.; Prince, M.; Prina, A.M. Associations of smoking and alcohol consumption with healthy ageing: A systematic review and meta-analysis of longitudinal studies. BMJ Open 2018, 8, e019540. [Google Scholar] [CrossRef] [PubMed]
- Warburton, D.E.R.; Nicol, C.W.; Bredin, S.S.D. Health benefits of physical activity: The evidence. CMAJ 2006, 174, 801–809. [Google Scholar] [CrossRef]
- Available online: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021244473 (accessed on 13 December 2021).
- Garg, A.X.; Adhikari, N.K.J.; McDonald, H.; Rosas-Arellano, M.P.; Devereaux, P.J.; Beyene, J.; Sam, J.; Haynes, R.B. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: A systematic review. J. Am. Med. Assoc. 2005, 293, 1223–1238. [Google Scholar] [CrossRef]
- Alonso-Pedrero, L.; Ojeda-Rodríguez, A.; Martinez-Gonzalez, M.A.; Zalba, G.; Bes-Rastrollo, M.; Marti, A. Ultra-processed food consumption and the risk of short telomeres in an elderly population of the Seguimiento Universidad de Navarra (SUN) Project. Am. J. Clin. Nutr. 2020, 111, 1259–1266. [Google Scholar] [CrossRef]
- Baba, Y.; Inagaki, S.; Nakagawa, S.; Kaneko, T.; Kobayashi, M.; Takihara, T. Effect of daily intake of green tea catechins on cognitive function in middle-aged and older subjects: A randomized, placebo-controlled study. Molecules 2020, 25, 4265. [Google Scholar] [CrossRef]
- Fernández-Real, J.M.; Bulló, M.; Moreno-Navarrete, J.M.; Ricart, W.; Ros, E.; Estruch, R.; Salas-Salvadó, J. A mediterranean diet enriched with olive oil is associated with higher serum total osteocalcin levels in elderly men at high cardiovascular risk. J. Clin. Endocrinol. Metab. 2012, 97, 3792–3798. [Google Scholar] [CrossRef] [PubMed]
- Fortin, A.; Rabasa-Lhoret, R.; Lemieux, S.; Labonté, M.E.; Gingras, V. Comparison of a Mediterranean to a low-fat diet intervention in adults with type 1 diabetes and metabolic syndrome: A 6–month randomized trial. Nutr. Metab. Cardiovasc. Dis. 2018, 28, 1275–1284. [Google Scholar] [CrossRef] [PubMed]
- Fretts, A.M.; Howard, B.V.; Siscovick, D.S.; Best, L.G.; Beresford, S.A.; Mete, M.; Eilat-Adar, S.; Sotoodehnia, N.; Zhao, J. Processed meat, but not unprocessed red meat, is inversely associated with leukocyte telomere length in the Strong Heart Family Study. J. Nutr. 2016, 146, 2013–2018. [Google Scholar] [CrossRef] [PubMed]
- García-Calzón, S.; Zalba, G.; Ruiz-Canela, M.; Shivappa, N.; Hébert, J.R.; Martínez, J.A.; Fitó, M.; Gómez-Gracia, E.; A Martínez-González, M.; Marti, A. Dietary inflammatory index and telomere length in subjects with a high cardiovascular disease risk from the PREDIMED-NAVARRA study: Cross-sectional and longitudinal analyses over 5 y. Am. J. Clin. Nutr. 2015, 102, 897–904. [Google Scholar] [CrossRef] [PubMed]
- García-Calzón, S.; Zalba, G.; Ruiz-Canela, M.; Shivappa, N.; Hébert, J.R.; Martínez, J.A.; Fitó, M.; Gómez-Gracia, E.; A Martínez-González, M.; Marti, A. Effects of the mediterranean diet supplemented with coenzyme Q10 on metabolomic profiles in elderly men and women. J. Gerontol. Ser. A 2015, 70, 78–84. [Google Scholar] [CrossRef]
- Gu, Y.; Honig, L.S.; Schupf, N.; Lee, J.H.; Luchsinger, J.A.; Stern, Y.; Scarmeas, N. Mediterranean diet and leukocyte telomere length in a multi-ethnic elderly population. Age 2015, 37, 24. [Google Scholar] [CrossRef]
- Guallar-Castillón, P.; Oliveira, A.; Lopes, C.; López-García, E.; Rodríguez-Artalejo, F. The Southern European Atlantic Diet is associated with lower concentrations of markers of coronary risk. Atherosclerosis 2013, 226, 502–509. [Google Scholar] [CrossRef]
- Mariscal, F.M.G.; Martínez, P.P.; Delgado-Lista, J.; Yubero-Serrano, E.M.; Camargo, A.; Delgado-Casado, N.; Cruz-Teno, C.; Santos-Gonzalez, M.; Rodriguez-Cantalejo, F.; Castaño, J.P.; et al. Mediterranean diet supplemented with coenzyme Q10 induces postprandial changes in p53 in response to oxidative DNA damage in elderly subjects. Age 2012, 34, 389–403. [Google Scholar] [CrossRef]
- Gutierrez-Mariscal, F.M.; Yubero-Serrano, E.M.; Rangel-Zúñiga, O.A.; Marín, C.; García-Rios, A.; Perez-Martinez, P.; Delgado-Lista, J.; Malagón, M.M.; Tinahones, F.J.; Pérez-Jimenez, F.; et al. Postprandial activation of P53-dependent DNA repair is modified by mediterranean diet supplemented with coenzyme Q10 in elderly subjects. J. Gerontol. Ser. A 2014, 69, 886–893. [Google Scholar] [CrossRef]
- Hernáez, Á.; Castañer, O.; Tresserra-Rimbau, A.; Pintó, X.; Fitó, M.; Casas, R.; Martínez-González, M.Á.; Corella, D.; Salas-Salvadó, J.; Lapetra, J.; et al. Mediterranean Diet and Atherothrombosis Biomarkers: A Randomized Controlled Trial. Mol. Nutr. Food Res. 2020, 64, 2000350. [Google Scholar] [CrossRef]
- Becerra-Tomás, N.; Paz-Graniel, I.; Tresserra-Rimbau, A.; Martínez-González, M.Á.; Barrubés, L.; Corella, D.; Muñoz-Martínez, J.; Romaguera, D.; Vioque, J.; Alonso-Gómez, Á.M.; et al. Fruit consumption and cardiometabolic risk in the PREDIMED-plus study: A cross-sectional analysis. Nutr. Metab. Cardiovasc. Dis. 2021, 31, 1702–1713. [Google Scholar] [CrossRef]
- Jalilpiran, Y.; Darooghegi Mofrad, M.; Mozaffari, H.; Bellissimo, N.; Azadbakht, L. Adherence to dietary approaches to stop hypertension (DASH) and Mediterranean dietary patterns in relation to cardiovascular risk factors in older adults. Clin. Nutr. ESPEN 2020, 39, 87–95. [Google Scholar] [CrossRef]
- Kanerva, N.; Loo, B.-M.; Eriksson, J.G.; Leiviskä, J.; Kaartinen, N.E.; Jula, A.; Männistö, S. Associations of the Baltic Sea diet with obesity-related markers of inflammation. Ann. Med. 2014, 46, 90–96. [Google Scholar] [CrossRef]
- Khalatbari-Soltani, S.; Marques-Vidal, P.; Imamura, F.; Forouhi, N.G. Prospective association between adherence to the Mediterranean diet and hepatic steatosis: The Swiss CoLaus cohort study. BMJ Open 2020, 10, e040959. [Google Scholar] [CrossRef]
- Kondo, K.; Ishikado, A.; Morino, K.; Nishio, Y.; Ugi, S.; Kajiwara, S.; Kurihara, M.; Iwakawa, H.; Nakao, K.; Uesaki, S.; et al. A high-fiber, low-fat diet improves periodontal disease markers in high-risk subjects: A pilot study. Nutr. Res. 2014, 34, 491–498. [Google Scholar] [CrossRef]
- Martens, R.J.H.; Henry, R.M.A.; Bekers, O.; Dagnelie, P.C.; Van Dongen, M.C.J.M.; Eussen, S.J.P.M.; Van Greevenbroek, M.; Kroon, A.A.; A Stehouwer, C.D.; Wesselius, A.; et al. Associations of 24-Hour Urinary Sodium and Potassium Excretion with Cardiac Biomarkers: The Maastricht Study. J. Nutr. 2020, 150, 1413–1424. [Google Scholar] [CrossRef]
- Martínez-Lapiscina, E.H.; Galbete, C.; Corella, D.; Toledo, E.; Buil-Cosiales, P.; Salas-Salvadó, J.; Ros, E.; Martinez-Gonzalez, M.A. Genotype patterns at CLU, CR1, PICALM and APOE, cognition and Mediterranean diet: The Predimed-Navarra trial. Genes Nutr. 2014, 9, 393. [Google Scholar] [CrossRef]
- Mofrad, M.D.; Namazi, N.; Larijani, B.; Surkan, P.J.; Azadbakht, L. Association of the Elderly Dietary Index with cardiovascular disease risk factors in elderly men: A cross-sectional study. Nutr. Diet. 2019, 76, 580–588. [Google Scholar] [CrossRef]
- Mujica-Parodi, L.; Amgalan, A.; Sultan, S.F.; Antal, B.; Sun, X.; Skiena, S.; Lithen, A.; Adra, N.; Ratai, E.-M.; Weistuch, C.; et al. Diet modulates brain network stability, a biomarker for brain aging, in young adults. Proc. Natl. Acad. Sci. USA 2020, 117, 6170–6177. [Google Scholar] [CrossRef]
- Neth, B.J.; Mintz, A.; Whitlow, C.; Jung, Y.; Sai, S.; Register, T.C.; Kellar, D.; Lockhart, S.N.; Maldjian, J.; Heslegrave, A.J.; et al. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease: A pilot study. Neurobiol. Aging 2020, 86, 54–63. [Google Scholar] [CrossRef]
- Paoli, A.; Cenci, L.; Grimaldi, K.A. Effect of ketogenic mediterranean diet with phytoextracts and low carbohydrates/high-protein meals on weight, cardiovascular risk factors, body composition and diet compliance in Italian council employees. Nutr. J. 2011, 10, 112. [Google Scholar] [CrossRef]
- Bhanpuri, N.H.; Hallberg, S.J.; Williams, P.T.; McKenzie, A.L.; Ballard, K.D.; Campbell, W.W.; McCarter, J.P.; Phinney, S.D.; Volek, J.S. Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: An open label, non-randomized, controlled study. Cardiovasc. Diabetol. 2018, 17, 56. [Google Scholar] [CrossRef]
- Schönknecht, Y.B.; Crommen, S.; Stoffel-Wagner, B.; Coenen, M.; Fimmers, R.; Holst, J.J.; Simon, M.; Stehle, P.; Egert, S. Acute Effects of Three Different Meal Patterns on Postprandial Metabolism in Older Individuals with a Risk Phenotype for Cardiometabolic Diseases: A Randomized Controlled Crossover Trial. Mol. Nutr. Food Res. 2020, 64, 1901035. [Google Scholar] [CrossRef]
- Song, X.; Kestin, M.; Schwarz, Y.; Yang, P.; Hu, X.; Lampe, J.W.; Kratz, M. A low-fat high-carbohydrate diet reduces plasma total adiponectin concentrations compared to a moderate-fat diet with no impact on biomarkers of systemic inflammation in a randomized controlled feeding study. Eur. J. Nutr. 2016, 55, 237–249. [Google Scholar] [CrossRef]
- Tiainen, A.-M.; Männistö, S.; Blomstedt, P.A.; Moltchanova, E.; Perälä, M.-M.; E Kaartinen, N.; Kajantie, E.; Kananen, L.; Hovatta, I.; Eriksson, J. Leukocyte telomere length and its relation to food and nutrient intake in an elderly population. Eur. J. Clin. Nutr. 2012, 66, 1290–1294. [Google Scholar] [CrossRef]
- Uusitupa, M.; Hermansen, K.; Savolainen, M.J.; Schwab, U.; Kolehmainen, M.; Brader, L.; Mortensen, L.S.; Cloetens, L.; Johansson-Persson, A.; Önning, G.; et al. Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome—A randomized study (SYSDIET). J. Intern. Med. 2013, 274, 52–66. [Google Scholar] [CrossRef]
- Yousefi, R.; Parandoosh, M.; Khorsandi, H.; Hosseinzadeh, N.; Tonekaboni, M.M.; Saidpour, A.; Babaei, H.; Ghorbani, A. Grape seed extract supplementation along with a restricted-calorie diet improves cardiovascular risk factors in obese or overweight adult individuals: A randomized, placebo-controlled trial. Phytother. Res. 2021, 35, 987–995. [Google Scholar] [CrossRef]
- Yubero-Serrano, E.M.; Gonzalez-Guardia, L.; Rangel-Zuñiga, O.; Delgado-Lista, J.; Gutierrez-Mariscal, F.M.; Perez-Martinez, P.; Delgado-Casado, N.; Cruz-Teno, C.; Tinahones, F.J.; Villalba, J.M.; et al. Mediterranean diet supplemented with coenzyme Q 10 Modifies the expression of proinflammatory and endoplasmic reticulum stress-related genes in elderly men and women. J. Gerontol. Ser. A 2012, 67, 3–10. [Google Scholar] [CrossRef]
- Boccardi, V.; Esposito, A.; Rizzo, M.R.; Marfella, R.; Barbieri, M.; Paolisso, G. Mediterranean Diet, Telomere Maintenance and Health Status among Elderly. PLoS ONE 2013, 8, e62781. [Google Scholar] [CrossRef] [PubMed]
- Bonaccio, M.; Di Castelnuovo, A.; Costanzo, S.; De Curtis, A.; Persichillo, M.; Sofi, F.; Cerletti, C.; Donati, M.B.; De Gaetano, G.; Iacoviello, L. Ultra-processed food consumption is associated with increased risk of all-cause and cardiovascular mortality in the Moli-sani Study. Am. J. Clin. Nutr. 2021, 113, 446–455. [Google Scholar] [CrossRef] [PubMed]
- Cassidy, A.; De Vivo, I.; Liu, Y.; Han, J.; Prescott, J.; Hunter, D.J.; Rimm, E.B. Associations between diet, lifestyle factors, and telomere length in women. Am. J. Clin. Nutr. 2010, 91, 1273–1280. [Google Scholar] [CrossRef] [PubMed]
- Chou, Y.C.; Lee, M.S.; Chiou, J.M.; Chen, T.F.; Chen, Y.C.; Chen, J.H. Association of diet quality and vegetable variety with the risk of cognitive decline in Chinese older adults. Nutrients 2019, 11, 1666. [Google Scholar] [CrossRef]
- Crous-Bou, M.; Fung, T.T.; Prescott, J.; Julin, B.; Du, M.; Sun, Q.; Rexrode, K.; Hu, F.B.; De Vivo, I. Mediterranean diet and telomere length in Nurses’ Health study: Population based cohort study. BMJ 2014, 349, g6674. [Google Scholar] [CrossRef]
- Rosario, V.A.D.; Chang, C.; Spencer, J.; Alahakone, T.; Roodenrys, S.; Francois, M.; Weston-Green, K.; Hölzel, N.; Nichols, D.S.; Kent, K.; et al. Anthocyanins attenuate vascular and inflammatory responses to a high fat high energy meal challenge in overweight older adults: A cross-over, randomized, double-blind clinical trial. Clin. Nutr. 2021, 40, 879–889. [Google Scholar] [CrossRef]
- D’Alessandro, A.; De Pergola, G. The Mediterranean Diet: Its definition and evaluation of a priori dietary indexes in primary cardiovascular prevention. Int. J. Food Sci. Nutr. 2018, 69, 647–659. [Google Scholar] [CrossRef]
- Fung, T.T.; Chiuve, S.E.; McCullough, M.L.; Rexrode, K.M.; Logroscino, G.; Hu, F.B. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch. Intern. Med. 2008, 168, 713–720. [Google Scholar] [CrossRef]
- Pérez-Guisado, J.; Muñoz-Serrano, A.; Alonso-Moraga, Á. Spanish Ketogenic Mediterranean diet: A healthy cardiovascular diet for weight loss. Nutr. J. 2008, 7, 30. [Google Scholar] [CrossRef]
- Krebs, H.A. The Regulation of the release of ketone bodies by the liver. Adv. Enzym. Regul. 1966, 4, 339–353. [Google Scholar] [CrossRef]
- Adamsson, V.; Reumark, A.; Cederholm, T.; Vessby, B.; Risérus, U.; Johansson, G. What is a healthy Nordic diet? Foods and nutrients in the NORDIET study. Food Nutr. Res. 2012, 56, 1145–1159. [Google Scholar] [CrossRef]
- Rajkumar, M.; Freitas, H. Influence of metal resistant-plant growth-promoting bacteria on the growth of Ricinus communis in soil contaminated with heavy metals. Chemosphere 2008, 71, 834–842. [Google Scholar] [CrossRef]
- Aune, D.; Keum, N.; Giovannucci, E.; Fadnes, L.T.; Boffetta, P.; Greenwood, D.C.; Tonstad, S.; Vatten, L.J.; Riboli, E.; Norat, T. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: Systematic review and dose-response meta-analysis of prospective studies. BMJ 2016, 353, i2716. [Google Scholar] [CrossRef]
- Lane, J.; Fontaine, K.R. Ketogenic Diet and Health. OBM Integr. Complementary Med. 2020, 6, 27. [Google Scholar] [CrossRef]
- Libby, P.; Ridker, P.M.; Hansson, G.K. Inflammation in Atherosclerosis. J. Am. Coll. Cardiol. 2009, 54, 2129–2138. [Google Scholar] [CrossRef]
- Kannel, W.B.; Anderson, K.; Wilson, P.W.F. White Blood Cell Count and Cardiovascular Disease. JAMA-J. Am. Med. Assoc. 1992, 267, 1253–1256. [Google Scholar] [CrossRef]
- Ridker, P.M.; Buring, J.E.; Shih, J.; Matias, M.; Hennekens, C.H. Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women. Circulation 1998, 98, 731–733. [Google Scholar] [CrossRef]
- Mattson, M.P.; Moehl, K.; Ghena, N.; Schmaedick, M.; Cheng, A. Intermittent metabolic switching, neuroplasticity and brain health. Nat. Rev. Neurosci. 2018, 19, 81–94. [Google Scholar] [CrossRef]
- Lambert, J.-C.; Heath, S.; Even, G.; Campion, D.; Sleegers, K.; Hiltunen, M.; Combarros, O.; Zelenika, D.; Bullido, M.J.; Tavernier, B.; et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’ s disease. Nat. Genet. 2009, 41, 1094–1099. [Google Scholar] [CrossRef]
- Harold, D.; Abraham, R.; Hollingworth, P.; Sims, R.; Gerrish, A.; Hamshere, M.L.; Pahwa, J.S.; Moskvina, V.; Dowzell, K.; Williams, A.; et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’ s disease. Nat. Genet. 2009, 41, 1088–1093. [Google Scholar] [CrossRef]
- Jun, G.; Naj, A.C.; Beecham, G.W.; Wang, L.-S.; Buros, J.; Gallins, P.J.; Buxbaum, J.D.; Ertekin-Taner, N.; Fallin, M.D.; Friedland, R.; et al. Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions with APOE Genotypes. Arch. Neurol. 2010, 67, 1473–1484. [Google Scholar] [CrossRef]
- Pedraza, O.; Allen, M.; Jennette, K.; Carrasquillo, M.; Crook, J.; Serie, D.; Pankratz, V.S.; Palusak, R.; Nguyen, T.; Malphrus, K.; et al. Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects. Alzheimer’s Dement. 2014, 10, 205–213. [Google Scholar] [CrossRef]
- Barral, S.; Bird, T.; Goate, A.; Farlow, M.R.; Diaz-Arrastia, R.; Bennett, D.A.; Graff-Radford, N.; Boeve, B.F.; Sweet, R.A.; Stern, Y.; et al. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory. Neurology 2012, 78, 1464–1471. [Google Scholar] [CrossRef]
- The SU.VI.MAX 2 Research Group; Kesse-Guyot, E.; Andreeva, V.; Lassale, C.; Ferry, M.; Jeandel, C.; Hercberg, S.; Galan, P. Mediterranean diet and cognitive function: A French study. Am. J. Clin. Nutr. 2013, 97, 369–376. [Google Scholar] [CrossRef] [PubMed]
- Tsivgoulis, G.; Judd, S.; Letter, A.J.; Alexandrov, A.V.; Howard, G.; Nahab, F.; Unverzagt, F.W.; Moy, C.; Howard, V.J.; Kissela, B.; et al. Adherence to a Mediterranean diet and risk of incident cognitive impairment. Neurology 2013, 80, 1684–1692. [Google Scholar] [CrossRef] [PubMed]
- Roberts, R.O.; Geda, Y.E.; Cerhan, J.; Knopman, D.S.; Cha, R.H.; Christianson, T.J.H.; Pankratz, V.S.; Ivnik, R.J.; Boeve, B.F.; O’Connor, H.M.; et al. Vegetables, Unsaturated Fats, Moderate Alcohol Intake, and Mild Cognitive Impairment. Dement. Geriatr. Cogn. Disord. 2010, 29, 413–423. [Google Scholar] [CrossRef] [PubMed]
- Scarmeas, N.; Stern, Y.; Mayeux, R.; Manly, J.J.; Schupf, N.; Luchsinger, J.A. Mediterranean Diet and Mild Cognitive Impairment. Arch. Neurol. 2009, 66, 216–225. [Google Scholar] [CrossRef]
- Baba, Y.; Inagaki, S.; Nakagawa, S.; Kobayashi, M.; Kaneko, T.; Takihara, T. Effects of Daily Matcha and Caffeine Intake on Mild Acute Psychological Stress-Related Cognitive Function in Middle-Aged and Older Adults: A Randomized Placebo-Controlled Study. Nutrients 2021, 13, 1700. [Google Scholar] [CrossRef]
- Ide, K.; Yamada, H.; Takuma, N.; Park, M.; Wakamiya, N.; Nakase, J.; Ukawa, Y.; Sagesaka, Y.M. Green Tea Consumption Affects Cognitive Dysfunction in the Elderly: A Pilot Study. Nutrients 2014, 6, 4032–4042. [Google Scholar] [CrossRef]
- Bayer-Carter, J.L.; Green, P.S.; Montine, T.J.; VanFossen, B.; Baker, L.D.; Watson, G.S.; Bonner, L.M.; Callaghan, M.; Leverenz, J.B.; Walter, S.K.; et al. Diet Intervention and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment. Arch. Neurol. 2011, 68, 743–752. [Google Scholar] [CrossRef]
- Caracciolo, B.; Xu, W.; Collins, S.; Fratiglioni, L. Cognitive decline, dietary factors and gut—Brain interactions. Mech. Ageing Dev. 2014, 136–137, 59–69. [Google Scholar] [CrossRef]
- Frisardi, V.; Panza, F.; Seripa, D.; Imbimbo, B.P.; Vendemiale, G. Nutraceutical Properties of Mediterranean Diet and Cognitive Decline: Possible Underlying Mechanisms. J. Alzheimer’s Dis. 2010, 22, 715–740. [Google Scholar] [CrossRef]
- Bottero, V.; Potashkin, J.A. A Comparison of Gene Expression Changes in the Blood of Individuals Consuming Diets Supplemented with Olives, Nuts or Long-Chain Omega-3 Fatty Acids. Nutrients 2020, 12, 3765. [Google Scholar] [CrossRef]
- Ferrucci, L.; Cherubini, A.; Bandinelli, S.; Bartali, B.; Corsi, A.; Lauretani, F.; Martin, A.; Andres-Lacueva, C.; Senin, U.; Guralnik, J.M. Relationship of Plasma Polyunsaturated Fatty Acids to Circulating Inflammatory Markers. J. Clin. Endocrinol. Metab. 2006, 91, 439–446. [Google Scholar] [CrossRef]
- O’Callaghan, N.; Parletta, N.; Milte, C.; Benassi-Evans, B.; Fenech, M.; Howe, P. Telomere shortening in elderly individuals with mild cognitive impairment may be attenuated with ω-3 fatty acid supplementation: A randomized controlled pilot study. Nutrition 2014, 30, 489–491. [Google Scholar] [CrossRef]
- Kiecolt-Glaser, J.K.; Epel, E.S.; Belury, M.A.; Andridge, R.; Lin, J.; Glaser, R.; Malarkey, W.B.; Hwang, B.S.; Blackburn, E. Omega-3 Fatty Acids, Oxidative Stress, and Leukocyte Telomere Length: A Randomized Controlled Trial. Brain Behav. Immun. 2014, 28, 16–24. [Google Scholar] [CrossRef]
- Di Daniele, N.; Noce, A.; Vidiri, M.F.; Moriconi, E.; Marrone, G.; Annicchiarico-Petruzzelli, M.; D’Urso, G.; Tesauro, M.; Rovella, V.; De Lorenzo, A. Impact of Mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget 2017, 8, 8947–8979. [Google Scholar] [CrossRef]
- de Deus Mendonça, R.; Lopes, A.C.S.; Pimenta, A.M.; Gea, A.; Martinez-Gonzalez, M.A.; Bes-Rastrollo, M. Ultra-Processed Food Consumption and the Incidence of Hypertension in a Mediterranean Cohort: The Seguimiento Universidad de Navarra Project. Am. J. Hypertens. 2017, 30, 358–366. [Google Scholar] [CrossRef]
- De Deus Mendonça, R.; Pimenta, A.M.; Gea, A.; De La Fuente-Arrillaga, C.; Martinez-Gonzalez, M.A.; Lopes, A.C.S.; Bes-Rastrollo, M. Ultraprocessed food consumption and risk of overweight and obesity: The University of Navarra Follow-Up (SUN) cohort study. Am. J. Clin. Nutr. 2016, 104, 1433–1440. [Google Scholar] [CrossRef]
- López-Suárez, A. Burden of cancer attributable to obesity, type 2 diabetes and associated risk factors. Metab. Clin. Exp. 2019, 92, 136–146. [Google Scholar] [CrossRef]
- Monteiro, C.A.; Levy, R.B.; Claro, R.M.; de Castro, I.R.; Cannon, G. Increasing Consumption of Ultra-Processed Foods and Likely Impact on Human Health: Evidence from Brazil. Public Health Nutr. 2011, 14, 5–13. [Google Scholar] [CrossRef]
- Nakamura, K.; Fuster, J.J.; Walsh, K. Adipokines: A link between obesity and cardiovascular disease. J. Cardiol. 2014, 63, 250–259. [Google Scholar] [CrossRef]
- Abdelaal, M.; Le Roux, C.W.; Docherty, N. Morbidity and mortality associated with obesity. Ann. Transl. Med. 2017, 5, 161. [Google Scholar] [CrossRef]
- Dinu, M.; Pagliai, G.; Casini, A.; Sofi, F. Mediterranean diet and multiple health outcomes: An umbrella review of meta-analyses of observational studies and randomised trials. Eur. J. Clin. Nutr. 2018, 72, 30–43. [Google Scholar] [CrossRef]
- Saneei, P.; Salehi-Abargouei, A.; Esmaillzadeh, A.; Azadbakht, L. Influence of Dietary Approaches to Stop Hypertension (DASH) diet on blood pressure: A systematic review and meta-analysis on randomized controlled trials. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 1253–1261. [Google Scholar] [CrossRef]
- Doostvandi, T.; Bahadoran, Z.; Mozaffari-Khosravi, H.; Mirmiran, P.; Azizi, F. Food intake patterns are associated with the risk of impaired glucose and insulin homeostasis: A prospective approach in the Tehran Lipid and Glucose Study. Public Health Nutr. 2016, 19, 2467–2474. [Google Scholar] [CrossRef]
- Puchau, B.; Zulet, M.A.; de Echávarri, A.G.; Hermsdorff, H.H.M.; Martínez, J.A. Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition 2010, 26, 534–541. [Google Scholar] [CrossRef]
- Al-Zahrani, M.S.; Bissada, N.F.; Borawski, E. Obesity and Periodontal Disease in Young, Middle-Aged, and Older Adults. J. Periodontol. 2003, 74, 610–615. [Google Scholar] [CrossRef]
- Paoli, A.; Bianco, A.A.; Grimaldi, K.; Lodi, A.; Bosco, G. Long Term Successful Weight Loss with a Combination Biphasic Ketogenic Mediterranean Diet and Mediterranean Diet Maintenance Protocol. Nutrients 2013, 5, 5205–5217. [Google Scholar] [CrossRef]
- Poudyal, H.; Panchal, S.K.; Diwan, V.; Brown, L. Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action. Prog. Lipid Res. 2011, 50, 372–387. [Google Scholar] [CrossRef]
- Wolever, T.M.S.; Bolognesi, C. Prediction of glucose and insulin responses of normal subjects after consuming mixed meals varying in energy, protein, fat, carbohydrate and glycemic index. J. Nutr. 1996, 126, 2807–2812. [Google Scholar] [CrossRef]
- Calder, P.C.; Ahluwalia, N.; Brouns, F.; Buetler, T.; Clement, K.; Cunningham, K.; Esposito, K.; Jönsson, L.S.; Kolb, H.; Lansink, M.; et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 2011, 106, S5–S78. [Google Scholar] [CrossRef]
- Lazarou, C.; Panagiotakos, D.B.; Chrysohoou, C.; Andronikou, C.; Matalas, A.L. C-Reactive protein levels are associated with adiposity and a high inflammatory foods index in mountainous Cypriot children. Clin. Nutr. 2010, 29, 779–783. [Google Scholar] [CrossRef]
- De Mello, V.D.F.; Schwab, U.; Kolehmainen, M.; Koenig, W.; Siloaho, M.; Poutanen, K.; Mykkänen, H.; Uusitupa, M. A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: The Sysdimet study. Diabetologia 2011, 54, 2755–2767. [Google Scholar] [CrossRef] [PubMed]
- Herder, C.; Brunner, E.J.; Rathmann, W.; Strassburger, K.; Tabák, A.G.; Schloot, N.C.; Witte, D.R. Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: The whitehall II study. Diabetes Care 2009, 32, 421–423. [Google Scholar] [CrossRef] [PubMed]
- Luotola, K.; Pietilä, A.; Zeller, T.; Moilanen, L.; Kähönen, M.; Nieminen, M.S.; Kesäniemi, Y.A.; Blankenberg, S.; Jula, A.; Perola, M.; et al. Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes. J. Intern. Med. 2011, 269, 322–332. [Google Scholar] [CrossRef] [PubMed]
- Carstensen, M.; Herder, C.; Kivimäki, M.; Jokela, M.; Roden, M.; Shipley, M.J.; Witte, D.R.; Brunner, E.J.; Tabák, A.G. Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study. Diabetes 2010, 59, 1222–1227. [Google Scholar] [CrossRef]
- Mozaffarian, D.; Micha, R.; Wallace, S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: A systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010, 7, e1000252. [Google Scholar] [CrossRef]
- Mozaffarian, D.; Appel, L.J.; Van Horn, L. Components of a cardioprotective diet: New insights. Circulation 2011, 123, 2870–2891. [Google Scholar] [CrossRef]
- Giannitsis, E.; Katus, H.A. Cardiac troponin level elevations not related to acute coronary syndromes. Nat. Rev. Cardiol. 2013, 10, 623–634. [Google Scholar] [CrossRef]
- Struthers, A.; Lang, C. The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent “pancardiac” target organ damage. Eur. Hear. J. 2007, 28, 1678–1682. [Google Scholar] [CrossRef]
- Aburto, N.J.; Hanson, S.; Gutierrez, H.; Hooper, L.; Elliott, P.; Cappuccio, F.P. Effect of increased potassium intake on cardiovascular risk factors and disease: Systematic review and meta-analyses. BMJ 2013, 346, f1378. [Google Scholar] [CrossRef]
- D’Elia, L.; Barba, G.; Cappuccio, F.P.; Strazzullo, P. Potassium Intake, Stroke, and Cardiovascular Disease. J. Am. Coll. Cardiol. 2011, 57, 1210–1219. [Google Scholar] [CrossRef]
- Mente, A.; O’Donnell, M.; Rangarajan, S.; McQueen, M.; Dagenais, G.; Wielgosz, A.; Lear, S.; Ah, S.T.L.; Wei, L.; Diaz, R.; et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: A community-level prospective epidemiological cohort study. Lancet 2018, 392, 496–506. [Google Scholar] [CrossRef]
- World Health Organization. Guideline: Potassium Intake for Adults and Children; World Health Organization: Geneva, Switzerland, 2012. [Google Scholar]
- Kim, H.; Hu, E.A.; Rebholz, C.M. Ultra-processed food intake and mortality in the USA: Results from the Third National Health and Nutrition Examination Survey. Public Health Nutr. 2019, 22, 1777–1785. [Google Scholar] [CrossRef]
- Srour, B.; Fezeu, L.K.; Kesse-Guyot, E.; Allès, B.; Méjean, C.; Andrianasolo, R.M.; Chazelas, E.; Deschasaux, M.; Hercberg, S.; Galan, P.; et al. Ultra-processed food intake and risk of cardiovascular disease: Prospective cohort study (NutriNet-Santé). BMJ 2019, 365, l1451. [Google Scholar] [CrossRef]
- Rico-Campà, A.; Martínez-González, M.A.; Alvarez-Alvarez, I.; de Deus Mendonça, R.; De La Fuente-Arrillaga, C.; Gómez-Donoso, C.; Bes-Rastrollo, M. Association between consumption of ultra-processed foods and all cause mortality: SUN prospective cohort study. BMJ 2019, 365, l1949. [Google Scholar] [CrossRef]
- Bennett, M.R. Reactive oxygen species and death: Oxidative DNA damage in atherosclerosis. Circ. Res. 2001, 88, 648–650. [Google Scholar] [CrossRef]
- Santos-González, M.; Gómez Díaz, C.; Navas, P.; Villalba, J.M. Modifications of plasma proteome in long-lived rats fed on a coenzyme Q10-supplemented diet. Exp. Gerontol. 2007, 42, 798–806. [Google Scholar] [CrossRef]
- Thomas, S.R.; Neužil, J.; Stocker, R. Cosupplementation with Coenzyme Q Prevents the Prpoxidant Effect of α-Tocopherol and Increases the Resistance of LDL to Transition Metal-Dependent Oxidation Initiation. Arter. Thromb. Vasc. Biol. 1996, 16, 687–696. [Google Scholar] [CrossRef]
- Ernster, L.; Dallner, G. Biochemical and physiological aspects of ubiquinone function. Membr. Cell Biol. 1995, 1271, 195–204. [Google Scholar] [CrossRef]
- Lass, A.; Forster, M.J.; Sohal, R.S. Effects of Coenzyme Q10 and a-tocopherol administration on their tissue levels in the mouse: Elevation of mitochondrial a-tocopherol by Coenzyme Q10. Free Radic. Biol. Med. 1999, 26, 1375–1382. [Google Scholar] [CrossRef]
- Ahmadzadeh, H.; Andreyev, D.; Arriaga, E.A.; Thompson, L.D.V. Capillary electrophoresis reveals changes in individual mitochondrial particles associated with skeletal muscle fiber type and age. J. Gerontol. Ser. A 2006, 61, 1211–1218. [Google Scholar] [CrossRef]
- Quiles, J.L.; Huertas, J.R.; Battino, M.; Ramírez-Tortosa, M.C.; Cassinello, M.; Mataix, J.; Lopez-Frias, M.; Mañas, M. The intake of fried virgin olive or sunflower oils differentially induces oxidative stress in rat liver microsomes. Br. J. Nutr. 2002, 88, 57–65. [Google Scholar] [CrossRef]
- Huertas, J.R.; Battino, M.; Lenaz, G.; Mataix, F.J. Changes in mitochondrial and microsomal rat liver coenzyme Q9, and Q10 content induced by dietary fat and endogenous lipid peroxidation. FEBS Lett. 1991, 287, 89–92. [Google Scholar] [CrossRef]
- Ramirez-Tortosa, M.C.; Urbano, G.; López-Jurado, M.; Nestares, T.; Gomez, M.C.; Mir, A.; Ros, E.; Mataix, J.; Gil, A. Extra-virgin olive oil increases the resistance of LDL to oxidation more than refined olive oil in free-living men with peripheral vascular disease. J. Nutr. 1999, 129, 2177–2183. [Google Scholar] [CrossRef]
- Vogelstein, B.; Lane, D.; Levine, A.J. Surfing p53 Network. Nature 2000, 408, 307–310. [Google Scholar] [CrossRef]
- Štraser, A.; Filipič, M.; Žegura, B. Genotoxic effects of the cyanobacterial hepatotoxin cylindrospermopsin in the HepG2 cell line. Arch. Toxicol. 2011, 85, 1617–1626. [Google Scholar] [CrossRef]
- Saito, T.; Shimazaki, Y. Metabolic disorders related to obesity and periodontal disease. Periodontol. 2000 2007, 43, 254–266. [Google Scholar] [CrossRef]
- Lakkis, D.; Bissada, N.F.; Saber, A.; Khaitan, L.; Palomo, L.; Narendran, S.; Al-Zahrani, M.S. Response to Periodontal Therapy in Patients Who Had Weight Loss After Bariatric Surgery and Obese Counterparts: A Pilot Study. J. Periodontol. 2011, 83, 684–689. [Google Scholar] [CrossRef] [PubMed]
- Kopp, W. How western diet and lifestyle drive the pandemic of obesity and civilization diseases. Diabetes Metab. Syndr. Obes. Targets Ther. 2019, 12, 2221–2236. [Google Scholar] [CrossRef] [PubMed]
- Christ, A.; Lauterbach, M.; Latz, E. Western Diet and the Immune System: An Inflammatory Connection. Immunity 2019, 51, 794–811. [Google Scholar] [CrossRef] [PubMed]
- Sharif, K.; Watad, A.; Bragazzi, N.L.; Lichtbroun, M.; Amital, H.; Shoenfeld, Y. Physical activity and autoimmune diseases: Get moving and manage the disease. Autoimmun. Rev. 2018, 17, 53–72. [Google Scholar] [CrossRef] [PubMed]
- Lippi, G.; Henry, B.M.; Sanchis-Gomar, F. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19). Eur. J. Prev. Cardiol. 2020, 27, 906–908. [Google Scholar] [CrossRef]
- Pedersen, B.K. Anti-inflammatory effects of exercise: Role in diabetes and cardiovascular disease. Eur. J. Clin. Investig. 2017, 47, 600–611. [Google Scholar] [CrossRef]
- Åberg, F.; Helenius-Hietala, J.; Puukka, P.; Färkkilä, M.; Jula, A. Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population. Hepatology 2018, 67, 2141–2149. [Google Scholar] [CrossRef]
- Kim, S.Y.; Min, C.; Oh, D.J.; Choi, H.G. Tobacco smoking and alcohol consumption are related to benign parotid tumor: A nested case-control study using a national health screening cohort. Clin. Exp. Otorhinolaryngol. 2019, 12, 412–419. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).